Introduction: Public policies aimed at improving medicine adherence are restricted to people with a low income or to social assistance recipients. Objective: To determine whether the free provision of essential medicines has a different effect on adherence for people with different income levels and sources. Methods: In this post-hoc subgroup analysis of results from the CLEAN Meds randomized control trial, binary logistic regression was used as the primary analysis to determine whether free medication provision has different effects at different income levels and sources. Results: Despite the evidence to suggest that the RCT intervention has a significant effect on adherence (p=0.02), there was no substantial difference in the effect of ...
To estimate the population-level causal effect of source of payment for HIV medication on treatment ...
Objective: To estimate the population-level causal effect of source of payment for HIV medication on...
BACKGROUND: Despite evidence that medication adherence can influence cost-effectiveness analysis (CE...
Introduction: Public policies aimed at improving medicine adherence are restricted to people with a ...
Introduction: The number of medicines prescribed to a patient can be an obstacle to medicine adheren...
Background Adherence to medicines is low for a variety of reasons, including the cost borne by patie...
Copayment policies aim to reduce the burden of medication expenditure but may affect adherence and g...
BackgroundAdherence to medicines is low for a variety of reasons, including the cost borne by patien...
Funding: This work is supported by the Canadian Institutes for Health Research (NP, 381409, https://...
This work is supported by grant 381409 from the Canadian Institutes for Health Research, the Ontario...
Copayments are intended to decrease third party expenditure on pharmaceuticals, particularly those r...
BACKGROUND: Increasing patient cost sharing is a commonly employed mechanism to contain health care ...
INTRODUCTION: Copayments are intended to decrease third party expenditure on pharmaceuticals, partic...
Introduction: Cost-related non-adherence to medicines is common in low-income, middle-income and hig...
Copayments for prescriptions may increase morbidity and mortality via reductions in adherence to med...
To estimate the population-level causal effect of source of payment for HIV medication on treatment ...
Objective: To estimate the population-level causal effect of source of payment for HIV medication on...
BACKGROUND: Despite evidence that medication adherence can influence cost-effectiveness analysis (CE...
Introduction: Public policies aimed at improving medicine adherence are restricted to people with a ...
Introduction: The number of medicines prescribed to a patient can be an obstacle to medicine adheren...
Background Adherence to medicines is low for a variety of reasons, including the cost borne by patie...
Copayment policies aim to reduce the burden of medication expenditure but may affect adherence and g...
BackgroundAdherence to medicines is low for a variety of reasons, including the cost borne by patien...
Funding: This work is supported by the Canadian Institutes for Health Research (NP, 381409, https://...
This work is supported by grant 381409 from the Canadian Institutes for Health Research, the Ontario...
Copayments are intended to decrease third party expenditure on pharmaceuticals, particularly those r...
BACKGROUND: Increasing patient cost sharing is a commonly employed mechanism to contain health care ...
INTRODUCTION: Copayments are intended to decrease third party expenditure on pharmaceuticals, partic...
Introduction: Cost-related non-adherence to medicines is common in low-income, middle-income and hig...
Copayments for prescriptions may increase morbidity and mortality via reductions in adherence to med...
To estimate the population-level causal effect of source of payment for HIV medication on treatment ...
Objective: To estimate the population-level causal effect of source of payment for HIV medication on...
BACKGROUND: Despite evidence that medication adherence can influence cost-effectiveness analysis (CE...